Codiak BioSciences, Inc. - stock earnings
Stock symbol CDAK is outdated, potentially delisted? Maybe it is available on other exchange?
CDAK Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -19.3 million USD | 522000 USD |
| 2022Q2 | -6.8 million USD | 13.1 million USD |
| 2022Q1 | -8.0 million USD | 12.7 million USD |
| 2021Q4 | 16.7 million USD | 7.7 million USD |
| 2021Q3 | -21.7 million USD | 1.2 million USD |
| 2021Q2 | -21.8 million USD | 890000 USD |
| 2021Q1 | -10.3 million USD | 13.2 million USD |
| 2020Q4 | -18.0 million USD | 1.6 million USD |
| 2020Q3 | -35.3 million USD | 954000 USD |
CDAK Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -37.2 million USD | 22.9 million USD |
| 2020 | -91.7 million USD | 2.9 million USD |
| 2019 | -78.0 million USD | 388000 USD |
| 2018 | -44.5 million USD | ? USD |
| 2017 | -27.0 million USD | ? USD |
CDAK
Price: $0.06
52 week price:
Earnings Per Share: -1.39 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 691900
Market Capitalization: 2.8 million